EXR
57
2
WU
34
-2
CMA
77
2
TRIP
70
10
RIG
23
-5
MMC
64
3
APA
46
-2
ALL
45
2
UPS
41
-4
SWK
46
-3
EMC
91
-5
MA
64
4
COST
50
2
NI
72
2
SEE
56
-3
ESS
42
2
AEP
64
2
STX
70
-3
AN
61
-2
FSLR
66
8
EXR
57
2
WU
34
-2
CMA
77
2
TRIP
70
10
RIG
23
-5
MMC
64
3
APA
46
-2
ALL
45
2
UPS
41
-4
SWK
46
-3
EMC
91
-5
MA
64
4
COST
50
2
NI
72
2
SEE
56
-3
ESS
42
2
AEP
64
2
STX
70
-3
AN
61
-2
FSLR
66
8
Financhill
Back

Dorman Products Vs. Lyra Therapeutics Industry Stock Comparison

Sell
47

DORM
Dorman Products

Last Price:
$128.02
Seasonality Move:
2.79%
Sell
32

LYRA
Lyra Therapeutics

Last Price:
$9.16
Seasonality Move:
-2.29%
Sell
47
Dorman Products (DORM) is a Sell

Is Dorman Products a Buy, Sell or Hold?

  • The current Dorman Products [DORM] share price is $128.09. The Score for DORM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • DORM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

  • The current Lyra Therapeutics [LYRA] share price is $9.00. The Score for LYRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DORM Stock Price Chart

What is Dorman Products's stock price today?

  • The Dorman Products share price today is $128.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DORM is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

  • The Lyra Therapeutics share price today is $9.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing slight selling pressure.

DORM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 57.41 Buy
Chaikin Money Flow: 59392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (123.3 - 127.96) Buy
Bollinger Bands (100): (117.45 - 129.55) Buy

LYRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 44.26 Sell
Chaikin Money Flow: -16263 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.53 - 19.57) Sell
Bollinger Bands (100): (4.06 - 13.18) Buy

DORM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 124.66 Buy
20-day SMA: 125.12 Buy
50-day SMA: 124.08 Buy
200-day SMA: 125.03 Buy
8-day EMA: 125.45 Buy
20-day EMA: 125.03 Buy
50-day EMA: 117.58 Buy
200-day EMA: 63.6 Buy

LYRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 12.91 Sell
50-day SMA: 9.32 Sell
200-day SMA: 9.78 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.05 Sell
50-day EMA: 10.19 Sell
200-day EMA: 21.81 Sell

Dorman Products Earnings Growth & DORM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Dorman Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):